Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma
Jane Yanagawa(University of California, Los Angeles), Steven M. Dubinett(University of California, Los Angeles), Camelia Dumitras(University of California, Los Angeles), Avrum Spira(Boston University), Adam C. Gower(Boston University), Gregory A. Fishbein(University of California, Los Angeles), Sarah A. Mazzilli(Boston University), Raymond J. Lim(University of California, Los Angeles), Bitta Kahangi(University of California, Los Angeles), Humam Kadara(The University of Texas MD Anderson Cancer Center), Ramin Salehi‐Rad(University of California, Los Angeles), Linh M. Tran(University of California, Los Angeles), Joshua D. Campbell(Broad Institute), Jennifer Beane(Boston University), Kostyantyn Krysan(University of California, Los Angeles), Denise R. Aberle, Conor Shea(Boston University), Ashley E. Prosper(University of California, Los Angeles), Rui Hong(Boston University), Marc E. Lenburg(Boston University), Bin Liu(University of California, Los Angeles), John Deng(University of California, Los Angeles), Eileen Fung(University of California, Los Angeles), William D. Wallace(University of California, Los Angeles)
Cited by 19
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k